Verification of Authenticity of Ginkgo biloba L. Leaf Extract and Its Products Present on the Croatian Market by Analysis of Quantity and Ratio of Ginkgo Flavone Glycosides (Quercetin, Kaempferol and Isorhamnetin) to Terpene Trilactones to the Effect of Unmasking Counterfeit Drugs Endangering Patient Health
Ginkgo biloba L. is the eldest plant growing on the Earth; preparations made of its leaves and seeds represent an integral part of the Chinese medicine for over a millennium. The plant species was first discovered by Linnaeus in 1771, its name thereby originating from the Latin words bis (two) and l...
Gespeichert in:
Veröffentlicht in: | Acta clinica Croatica (Tisak) 2019-12, Vol.58 (4), p.672-692 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Ginkgo biloba
L. is the eldest plant growing on the Earth; preparations made of its leaves and seeds represent an integral part of the Chinese medicine for over a millennium. The plant species was first discovered by Linnaeus in 1771, its name thereby originating from the Latin words
bis
(two) and
lobus
(lobe), which duly illustrate the specific shape of its leaf. Contemporary
Ginkgo biloba
L. plant based pharmaceuticals mostly comprise extracts recovered from leaves harvested during fall, when the concentration of active components reaches its peak. Recent investigations have managed to establish the chemical composition of the plant leaf, together with the mechanisms underlying its beneficial effects on rheological profile of the blood and acceleration of its flow. High price of these preparations and their vast popularity have soon become an incentive for counterfeiting
Ginkgo biloba
L. extracts and the release of bogus drugs comprising cheaper extracts coming from other plants. Namely, modern
Ginkgo biloba
L.-based medicinal products and food supplements comprise extracts recovered from the plant leaf that get to be standardized according to its key pharmacological active components, most often flavone glycosides (represented in the share of 22%-27%) and terpene trilactones (represented in the share of 6%-7%). The flavonoids that predominate such preparations and are most relevant from the pharmacological standpoint are quercetin, kaempferol and isorhamnetin, their total amount and mutual ratios, thereby being an unquestionable indicator of the extract authenticity. Therefore, most of the analyses aiming at verifying the authenticity of a given
Ginkgo biloba
L.-based product boil down to the analysis of these parameters. Counterfeiting involves partial or full replacement of the
Ginkgo biloba
L. extract (GBE) with a cheaper plant extract of a similar composition, the latter occasionally being enriched with an additional amount of flavonoids, most often quercetin, not originating from the
Ginkgo biloba
L. plant. The aim of this study was to verify the authenticity and quality of
Ginkgo biloba
L.-based products circulating on the Croatian market. To that effect, 10 samples of products produced by various manufacturers were analyzed in a certified laboratory. The parameters based on which the authenticity of the preparations was assessed were the shares of aglycones of typical ginkgo flavone glycosides, that is to say, quercetin, kaempferol and isorhamnet |
---|---|
ISSN: | 0353-9466 1333-9451 |
DOI: | 10.20471/acc.2019.58.04.15 |